Synergistic effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin and n-nitrosodiethylamine on cell malignant transformation

Biomedical and Environmental Sciences

Volumn 26, Issue 5, 2013, Pages 323-330

  Lei, Zhang ^a   Rui, Zhao ^b   Qing, Ye Shu ^c   Ling, Zhou ^c   Ning, Wu Yong ^a   Yi, Zeng ^c  

^a CHINA NATIONAL CENTER FOR FOOD SAFETY RISK ASSESSMENT   (China)

^b BEIJING UNIVERSITY OF TECHNOLOGY   (China)

^c CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

Cell transformation; Dioxin; Nitrosodiethylamine; Tumorigenesis

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; AROMATIC HYDROCARBON RECEPTOR; CARCINOGEN; CYTOCHROME P450; DIETHYLNITROSAMINE; DIOXIN; MESSENGER RNA; PRIMER DNA;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; CARCINOGENESIS; CELL STRAIN 3T3; CELL TRANSFORMATION; DRUG POTENTIATION; GENETICS; METABOLISM; MOUSE; NUCLEOTIDE SEQUENCE; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

CELL TRANSFORMATION; DIOXIN; NITROSODIETHYLAMINE; TUMORIGENESIS;

3T3 CELLS; ANIMALS; BASE SEQUENCE; CARCINOGENS; CELL TRANSFORMATION, NEOPLASTIC; CYTOCHROME P-450 ENZYME SYSTEM; DIETHYLNITROSAMINE; DNA PRIMERS; DRUG SYNERGISM; MICE; MICE, INBRED BALB C; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, ARYL HYDROCARBON; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TETRACHLORODIBENZODIOXIN;

MLCS; MLOWN;

EID: 84881218679     PISSN: 08953988     EISSN: None     Source Type: Journal    
DOI: 10.3967/0895-3988.2013.05.001     Document Type: Article

References (45)

1. Steenland K, Bertazzi P, Baccarelli A, et al. Dioxin revisited: developments since the 1997 IARC classification of dioxin as a human carcinogen. Environ Health Perspect, 2004; 112(13), 1265-8.
2. Mandal PK. Dioxin: a review of its environmental effects and its aryl hydrocarbon receptor biology. J Comp Physiol, 2005; 175(4), 221-30.
3. Kashuba EV, Gradin K, Isaguliants M, et al. Regulation of transactivation function of the aryl hydrocarbon receptor by the Epstein-Barr virus-encoded EBNA-3 protein. J Biol Chem, 2006; 281(2), 1215-23.
4. IARC. IARC working group on the evaluation of carcinogenic risks to humans. Polychlorinated dibenzo-para-dioxins and polychlorinated dibenzofurans. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 69. International Agency for Research on Cancer, Lyon. 1997.
5. Tricker AR and Preussmann R. Carcinogenic N-nitrosamines in the diet: occurrence, formation, mechanisms and carcinogenic potential. Mutat Res, 1991; 259, 277-89.
6. Bogovski P and Bogovski S. Animal species in which N-nitroso compounds induce cancer. Int.J. Cancer, 1981; 27, 471-4.
7. WHO/IARC. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol.17. Some N-nitroso compounds. International Agency for Research on Cancer, Lyon. 1998.
8. Wu YN. Present Knowledge in Food Safety. Beijing: Chemical Industry Press, 2003; 204-31. (In Chinese)
9. Nollet LML and Toldra F. Safety analysis of foods of animal origin. New York: CRC Press, 2011; 421-6.
10. Perocco P, Paolini M, Mazzullo M, et al. Carotene as enhancer of cell transforming activity of powerful carcinogens and cigarette-smoke condensate on BALB/c 3T3 cells in vitro. Mutat Res, 1999; 440(1), 83-90.
11. Perocco P, Iori R, Barillari J, et al. In vitro induction of benzo(a)pyrene cell-transforming acivity by the glucosinolate gluconasturiin found in cruciferous vegetables. Cancer Lett, 2002; 184(1), 65-71.
12. Wang LW, Zhong WJ, Ying XP, et al. Study on the Effects of Genistein on the Transformaion of BALB/c-3T3 Cells. Carcinogenesis, Teratogenesis & Mutagenesis, 2005; 17(1), 48-51.
13. Arpiainen S, Raffalli-Mathieu F, Lang MA, et al. Regulaion of the Cyp2a5 gene involves an aryl hydrocarbon-dependent pathway. Mol Pharmacol, 2005; 67(4), 1325-33.
14. Godoy W, Albano RM, Moraes EG, et al. CYP2A6/2A7 and CYP2E1 expression in human oesophageal mucosa: regional and inter-individual variaion in expression and relevance to nitrosamine metabolism. Carcinogenesis, 2002; 23(4), 611-6.
15. Sakai A , Iwase Y , Nakamura Y, et al. Use of a cell transformaion assay with established cell lines, and a metabolic cooperaion assay with V79 cells for the detecion of tumor promoters: a review. ATLA, 2002; 30, 33-59.
16. Combes R, Balls M, Curren R, et al. Cell transformaion assay as predictors of human carcinogenicity. The report and recommendaion of ECVAM Workshop 39. ATLA, 1999; 27, 745-67.
17. McGregor DB, Rice JM & Venitt S, eds. The Use of Short-And Medium-term Tests for Carcinogens and Data on Geneic Effects in Carcinogenic Hazard Evaluaion (IARC Scienific Publicaions No. 146), Lyon: IARC press, 1999. (http://monographs.iarc.fr/ENG/Publicaions/pub146/IARCpub 146.pdf).
18. Sakai A. Balb/c 3T3 cell transformaion assays for the assessment of chemical carcinogenicity. AATEX, 2007; 14(Special Issue), 367-73.
19. IARC/NCI/EPA Working group. Cellular and molecular mechanisms of cell transformaion and standardizaion carcinogenic chemicals: overview and recommended protocols. Cancer Res, 1985; 45(5), 2395-9.
20. Abu-Bakar A, Satarug S, Marks GC, et al. Acute cadmium chloride administraion induces hepaic and renal Cyp2a5 mRNA, protein and acivity in the mouse: involvement of transcripion factor NRF2. Toxicol Lett, 2004; 148(3), 199-210.
21. Chun YJ, Lee BY, Yang SA, et al. Inducion of Cytochrome P450 1A1 Gene Expression by a Vitamin K3 Analog in Mouse Hepatoma Hepa-1c1c7 Cells. Mol Cells, 2001; 12(2), 190-6.
22. Tsuchiya T, Umeda M. Improvement in the efficiency of the in vitro transformaion assay method using BALB/3T3 A31-1-1 cells. Carcinogensis, 1995; 16(8), 1887-94.
23. Kajiwara Y, Ajimi S, Hosokawa A, et al. Improvement of carcinogen detecion in the BALB/3T3 cell transformaion assay by using a rich basal medium supplemented with low concentraion of serum and some growth factors. Mutat Res, 1997; 393(1-2), 81-90.
24. Kajiwara Y, Ajimi S. Verificaion of the BALB/c 3T3 cell transformaion assay atter improvement by using an ITES-medium. Toxicol in Vitro, 2003; 17(4), 489-96.
25. Asada S, Sasaki K, Tanaka N, et al. Detecion of iniiaing as well as promoing acivity of chemicals by a novel cell transformaion assay using v-Ha-ras-transfected BALB/c 3T3 cells (Bhas 42 cells). Mutat Res, 2005; 588(1), 7-21.
26. Fang MZ, Kim DY, Lee HW, et al. Improvement of in vitro two-stage transformaion assay and determinaion of the promoional effect of cadmium. Toxicol in vitro, 2001; 15(3), 225-31.
27. Viluksela M, Bager Y, Tuomisto JT, et al. Liver Tumor-promoing Acivity of 2,3,7,8-Tetrachloro-dibenzo-p-dioxin (TCDD) in TCDD-sensiive and TCDD-resistant Rat Strains. Cancer res, 2000; 60, 6911-20.
28. Beebe LE, Fornwald LW, Diwan BA, et al. Promoion of N- Nitrosodiethylamine-iniiated Hepatocellular Tumors and Hepatoblastomas by 2,3,7,8-Tetrachlorodibenzo-p-dioxin or Aroclor 1254 in C57BL/6, DBA/2, and B6D2F1 Mice. Cancer Res, 1995; 55(21), 4875-80.
29. Wang YJ, Chang H, Kuo YC, et al. Synergism between 2,3,7,8- tetrachlorodibenzo-p-dioxin and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone on lung tumor incidence in mice. J Hazard Mater, 2011; 186(1), 869-75.
30. Whitlock JP Jr. Inducion of cytochrome P4501A1. Annu Rev Pharmacol Toxicol, 1999; 39, 103-25.
31. Ma Q, Lu AY. CYP1A Inducion and Human Risk Assessment: An Evolving Tale of in Vitro and in Vivo Studies. Drug Metab Dispos, 2007; 35(7), 1009-16.
32. Su T, Ding X. Regulaion of the cytochrome P450 2A genes. Toxicol Appl Pharmacol, 2004; 199(3), 285-94.
33. Seubert JM, Webb CD, and Bend JR. Acute sodium arsenite treatment induces Cyp2a5 but not Cyp1a1 in the C57B1/6 mouse in a issue (kidney) selecive manner. J Biochem Mol Toxicol, 2002; 16(2), 96-106.
34. Hukkanen J. Xenobioic-Metabolizing Cytochrome P450 Enzymes in Human Lung. Oulu: Oulu university press, 2000; 15-24.
35. Wastl UM, Rossmanith W, Lang MA, et al. Expression of cytochrome P450 2A5 in preneoplasic and neoplasic mouse liver lesions. Mol Carcinog, 1998; 22(4), 229-34.
36. El Gendy MA, Soshilov AA, et al. Transcripional and posttranslaional inhibiion of dioxin-mediated inducion of Cyp1a1 by harmine and harmol. Toxicol Lett, 2012; 208(1), 51-61.
37. Cole P, Trihopoulos D, pasides H, et al. Dioxin and cancer: a criical review. Regul Toxicol Pharmacol, 2003; 38, 378-88.
38. Nukaya M, Moran S, Bradfield CA. The role of the dioxin-responsive element cluster between the Cyp1a1 and Cyp1a2 loci in aryl hydrocarbon receptor biology. Proc Natl Acad Sci USA, 2009; 106(12), 4923-8.
39. Corton JC, Moreno ES, Hovis SM, et al. Idenificaion of a cell-specific transcripion acivaion domain within the human Ah receptor nuclear translocator. Toxicol Appl Pharmacol, 1996; 139(2), 272-80.
40. Ma Q, Dong L, Whitlock JP Jr. Transcripional acivaion by the mouse Ah receptor. Interplay between muliple simulatory and inhibitory funcions. J Biol Chem, 1995; 270(21), 12697-703.
41. Merchant M, Morrison V, Santostefano M, et al. Mechanism of acion of aryl hydrocarbon receptor antagonists: inhibiion of 2,3,7,8-tetrachlorodibenzo-p- dioxin-induced Cyp1a1 gene expression. Arch Biochem Biophys, 1992; 298(2), 389-94.
42. Isfort RJ, LeBoeuf RA. Applicaion of in vitro cell transformaion assays to predict the carcinogenic potenial of chemicals. Mutat Res, 1996; 365, 161-73.
43. Kajta M, Wójtowicz AK, Mackowiak M, et al. Aryl hydrocarbon receptor-mediated apoptosis of neuronal cells: a possible interacion with estrogen receptor signaling. Neuroscience, 2009; 158(2), 811-22.
44. Tian Y, Ke S, Denison MS, et al. Ah Receptor and NF-kB Interacions, a Potenial Mechanism for Dioxin Toxicity. J Biol Chem, 1999; 274(1), 510-5.
45. Tian Y, Rabson AB, Gallo MA. Ah receptor and NF-kappaB interacions: mechanisms and physiological implicaions. Chem Biol Interact, 2002; 141(1-2), 97-115.